Atlas Trials

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes

Clinical trial NCT01711606 · TERMINATED

Trial details

NCT number
NCT01711606
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Study type
OBSERVATIONAL
Fragile-X Syndrome
Start date
2013-03-01
Primary completion
2016-01-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.